ARA-290 (10mg) Preclinical data indicate improved exercise

Preclinical data indicate improved exercise endurance and a shift in muscle fiber composition toward oxidative phenotypes

enhancing immune response

improved insulin sensitivity

and normalized stress-induced alterations in catecholamine and serotonin turnover

For laboratory research use only

ARA-290 (10mg) Preclinical data indicate improved exerciseARA 290 Overview ARA 290, also known as cibinetide, is an 11 amino acid linear synthetic peptide derived from the helix B region of erythropoietin (EPO). It selectively activates the innate repair receptor (IRR; common receptor CD131 heterodimer) without stimulating erythropoiesis. It is widely used in laboratory and preclinical research as a model compound to investigate tissue protection, resolution of inflammation, neuropathic pain modulation,